Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection
in vitro
and
in vivo, Emerging Microbes & Infections, January 2014, Taylor & Francis,
DOI: 10.1038/emi.2014.60.
You can read the full text:
Contributors
The following have contributed to this page